{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:40Z","timestamp":1792789720378,"version":"4.5.0"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Project SHARP JA","award":["848096"],"award-info":[{"award-number":["848096"]}]},{"name":"Italian Ministry of Health","award":["848096"],"award-info":[{"award-number":["848096"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The definitive diagnosis of the Rift Valley fever virus (RVFV) requires a form of testing that is available only in reference laboratories. It includes indirect immunofluorescence assay (IFA), the serum neutralization assay (NA), and real-time PCR. Therefore, often, no attempts are made to detect it, even among travelers from endemic areas. In this study, the presence of anti-RVFV IgG and IgM was retrospectively screened in stored serum samples from people who were admitted with arbovirus symptoms at the National Institute for Infectious Diseases (INMI) L. Spallanzani, Rome, Italy. Overall, 80 residual serum samples were anonymized, and sub-aliquots were prepared and tested for anti-RVFV IgG and IgM. A serum neutralization assay was used as a confirmatory test. There was a positive result in eight out of 80 samples (10%) for anti-RVFV IgG, with titers ranging from 1:40 up to 1:1280. Three of eight (2.6%) samples were confirmed as seropositive through an in-house serum neutralization assay, with antibody titers ranging from 1:10 to 1:160. All samples resulted negative for anti-RVFV IgM and RVFV RNA when tested by IFA and real-time RT-PCR, respectively. Our data highlight that several RVFV infections can possibly escape routine virological diagnosis, which suggests RVFV testing should be set up in order to monitor virus prevalence.<\/jats:p>","DOI":"10.3390\/microorganisms11082081","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T10:20:14Z","timestamp":1692008414000},"page":"2081","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Detection of Anti-Rift Valley Fever Virus Antibodies in Serum Samples of Patients with Suspected Arbovirus Infection"],"prefix":"10.3390","volume":"11","author":[{"given":"Daniele","family":"Lapa","sequence":"first","affiliation":[{"name":"Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-3417","authenticated-orcid":false,"given":"Eliana","family":"Specchiarello","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-9237","authenticated-orcid":false,"given":"Massimo","family":"Francalancia","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-5896","authenticated-orcid":false,"given":"Enrico","family":"Girardi","sequence":"additional","affiliation":[{"name":"Scientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Maggi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rosa","family":"Garbuglia","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani (IRCCS), 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e006623","DOI":"10.1136\/bmjgh-2021-006623","article-title":"Scoping future outbreaks: A scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases","volume":"6","author":"Jonkmans","year":"2021","journal-title":"BMJ Glob. Health"},{"key":"ref_2","unstructured":"(2023, July 12). European Centre for Disease Prevention and Control Home Page. Facts about Rift Valley Fever. Available online: https:\/\/www.ecdc.europa.eu\/en\/rift-valley-fever\/facts."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1016\/j.vaccine.2015.08.020","article-title":"Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe","volume":"33","author":"Mansfield","year":"2015","journal-title":"Vaccine"},{"key":"ref_4","unstructured":"World Health Organization (2023, July 05). Efficacy Trials of Rift Valley Fever Vaccines and Therapeutics Guidance on Clinical Trial Design. Meeting Report. Available online: https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/rift-valley-fever-blueprint-trial-design-meeting-report-2019.pdf?sfvrsn=ee74e0fb_3."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1099\/jgv.0.001296","article-title":"Rift Valley fever: Biology and epidemiology","volume":"100","author":"Wright","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_6","unstructured":"Centers for Disease Control and Prevention (2023, June 08). Available online: https:\/\/www.cdc.gov\/vhf\/rvf\/diagnosis\/index.html."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Martinet, J.P., Fert\u00e9, H., Failloux, A.B., Schaffner, F., and Depaquit, J. (2019). Mosquitoes of North-Western Europe as potential vectors of arboviruses: A review. Viruses, 11.","DOI":"10.3390\/v11111059"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.17-0104","article-title":"Rift Valley Fever Seroprevalence in Coastal Kenya","volume":"97","author":"Banda","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.14-0575","article-title":"Elevated antibodies against Rift Valley fever virus among humans with exposure to ruminants in Saudi Arabia","volume":"92","author":"Memish","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_10","first-page":"1","article-title":"Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia","volume":"28","author":"Bosworth","year":"2015","journal-title":"New Microbes New Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0972-9062.302042","article-title":"Serological evidence of Rift Valley fever virus among humans in Mersin province of Turkey","volume":"56","author":"Kurnaz","year":"2019","journal-title":"J. Vector Borne Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ly, H.J., Lokugamage, N., Nishiyama, S., and Ikegami, T. (2017). Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain. PLoS ONE., 12.","DOI":"10.1371\/journal.pone.0185194"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-018-1611-y","article-title":"Molecular aspects of Rift Valley fever virus and the emergence of reassortants","volume":"55","author":"Gaudreault","year":"2019","journal-title":"Virus Genes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3201\/eid2012.140787","article-title":"Ngari virus in goats during Rift Valley fever outbreak, Mauritania, 2010","volume":"20","author":"Eiden","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","unstructured":"(2023, May 28). Qiagen RNeasy Mini Handbook. Available online: https:\/\/www.qiagen.com\/us\/resources\/resourcedetail?id=14e7cf6e-521a-4cf7-8cbc-bf9f6fa33e24&lang=en."},{"key":"ref_16","unstructured":"Altona Diagnostics (2023, July 02). RealStar\u00ae Rift Valley Fever Virus RT-PCR Kit 1.0. Available online: https:\/\/www.altona-diagnostics.com\/en\/products\/reagents-140\/reagents\/realstar-real-time-pcr-reagents\/realstar-rvfv-rt-pcr-kit-ce.html."},{"key":"ref_17","unstructured":"Altona Diagnostics (2023, June 12). Available online: https:\/\/www.altona-diagnostics.com\/files\/public\/Content%20Homepage\/-%2002%20RealStar\/MAN%20-%20CE%20-%20EN\/RealStar%20RVFV%20RT-PCR%20Kit%201.0_WEB_CE_EN-S02.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3201\/eid2712.210643","article-title":"Rift Valley Fever Virus Seroprevalence among Humans, Northern KwaZulu-Natal Province, South Africa, 2018\u20132019","volume":"27","author":"Msimang","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijid.2022.07.012","article-title":"Rift Valley fever seropositivity in humans and domestic ruminants and associated risk factors in Sengerema, Ilala, and Rufiji districts, Tanzania","volume":"122","author":"Sindato","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pourrut, X., Nkogh\u00e9, D., Souris, M., Paupy, C., Paweska, J., Padilla, C., Moussavou, G., and Leroy, E.M. (2010). Rift Valley fever virus seroprevalence in human rural populations of Gabon. PLoS Negl. Trop. Dis., 27.","DOI":"10.1371\/journal.pntd.0000763"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.20506\/rst.33.3.2328","article-title":"Seroepidemiological survey on Rift Valley fever among small ruminants and their close human contacts in Makkah, Saudi Arabia, in 2011","volume":"33","author":"Mohamed","year":"2014","journal-title":"Rev. Sci. Tech."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/vbz.2008.0009","article-title":"Potential vectors of Rift Valley fever virus in the Mediterranean region","volume":"8","author":"Moutailler","year":"2008","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4269\/ajtmh.2007.76.827","article-title":"Short report: Efficient oral infection of Culex pipiens quinquefasciatus by Rift Valley fever virus using a cotton stick support","volume":"76","author":"Moutailler","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_24","unstructured":"(2023, June 23). European Environment Agency Infectious Disease. Available online: https:\/\/discomap.eea.europa.eu\/climatechange\/?page=Infectious-diseases."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4103\/0972-9062.256570","article-title":"Preliminary serological investigation of Rift Valley fever in Poland","volume":"55","author":"Bazanow","year":"2018","journal-title":"J. Vector Borne Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Szymczak, M.S., Reeves, W.K., and Miller, M.M. (2021). Further Characterization of Rio Grande Virus and Potential for Cross Reactivity with Rift Valley Fever Virus Assays. Viruses, 13.","DOI":"10.3390\/v13091719"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2200270","DOI":"10.2807\/1560-7917.ES.2023.28.7.2200270","article-title":"Arthropod-borne diseases among travellers arriving in Europe from Africa, 2015 to 2019","volume":"28","author":"Gossner","year":"2023","journal-title":"Eurosurveillance"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/1469-0691.12163","article-title":"Relevance of Rift Valley fever to public health in the European Union","volume":"19","author":"Chevalier","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","first-page":"1863980","article-title":"Development and Validation of Rapid Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification for Detection of Rift Valley Fever Virus","volume":"30","author":"Wekesa","year":"2023","journal-title":"Adv. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"C\u00eatre-Sossah, C., P\u00e9darrieu, A., Juremalm, M., Jansen Van Vuren, P., Brun, A., Ould El Mamy, A.B., H\u00e9raud, J.M., Filippone, C., Ravalohery, J.P., and Chaabihi, H. (2019). Development and validation of a pen side test for Rift Valley fever. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007700"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/8\/2081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:32:55Z","timestamp":1760128375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/8\/2081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["microorganisms11082081"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11082081","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]}}}